Trading Concept
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Trading Concept
No Result
View All Result
Home Trading News

Altria can’t sell Iqos in the U.S. as Biden administration opts to not intervene in patent dispute

by
November 30, 2021
in Trading News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Schedule for Week of October 1, 2023

Disney, DeSantis legal fights ratchet up as company demands documents from Florida governor

Philip Morris International shows an iQOS electronic cigarette, which heats tobacco sticks but does not burn them.

Fabrice Coffrini | AFP | Getty Images

Altria and Philip Morris International are no longer able to sell or import Iqos tobacco devices in the U.S. after the Biden administration opted to take no action on an ongoing patent dispute.

Rival R.J. Reynolds, a subsidiary of British American Tobacco, had filed a claim with the U.S. International Trade Commission. In late September, the ITC ruled that the Iqos device infringed on two of Reynolds’ patents. As part of the process, the Biden administration conducted a 60-day administrative review and decided to not take any action to reverse the ITC’s decision.

“Today’s announcement provides a measure of success for our enforcement of IP rights to ensure we can continue to innovate, as is common practice among innovation-based industries,” British American Tobacco Assistant General Counsel Gareth Cooper said in a statement.

Altria launched the Iqos device in the United States two years ago, but it began development of the product more than a decade ago before Philip Morris was spun off from the company. The device heats tobacco without burning it, which is meant to give users the same rush of nicotine without as many toxins as smoking a cigarette.

Philip Morris sells the device in dozens of international markets and has granted Altria a license to sell it in the U.S. While Iqos doesn’t represent a large portion of Altria’s U.S. business, it’s part of the company’s shift away from traditional tobacco products, which have seen falling demand. Altria said it counts 20,000 U.S. consumers as users of the device, but they will no longer be able to purchase it in the U.S.

This isn’t the end of the patent dispute between Reynolds, Altria and Philip Morris. Reynolds also filed a claim with the U.S. Patent and Trademark Office over Iqos. That process is expected to take six to 12 months, although decisions can be appealed, which could drag it out even longer.

“While this decision will cause near-term disruption, we continue to see a large opportunity for IQOS and other FDA authorized smoke-free products in the U.S. over the coming years,” Philip Morris said in a statement.

Philip Morris also said that its contingency plans to return to the U.S. are underway. The two companies could move production to the U.S. or change up the design enough to avoid patent infringement claims.

Shares of British American Tobacco were down 1% in premarket trading on Tuesday, while the stocks of Altria and Philip Morris had both fallen less than 1%.

ShareTweetPin

Related Posts

Schedule for Week of October 1, 2023

by
October 1, 2023
0

by Calculated Risk on 9/30/2023 08:11:00 AM The key report scheduled for this week is the September employment report on...

Disney, DeSantis legal fights ratchet up as company demands documents from Florida governor

by
October 1, 2023
0

S&P 500 4,288.05 -11.65(-0.27%)   Dow 30 33,507.50 -158.84(-0.47%)   Nasdaq 13,219.32 +18.05(+0.14%)   Russell 2000 1,785.10 -9.21(-0.51%)   Crude...

Dow Jones Futures Loom With Government Shutdown Averted; Tesla Deliveries Due

by
October 1, 2023
0

Post Content

9 Stocks Turn $10,000 Into $139,936 In 9 Months

by
October 1, 2023
0

Post Content

Beyonce’s Renaissance World Tour in talks with AMC for a concert film

by
October 1, 2023
0

Beyonce performs onstage during the Renaissance World Tour. Kevin Mazur | Wireimage | Getty Images Beyonce's Renaissance World Tour may...

Next Post

IBD 50 Stocks To Watch: This Chip Stock Continues Higher On Shortages, Record Backlog

Dow futures are down 300 points as investors try to gauge the economic impact of omicron

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • WHO says Covid vaccine booster programs will prolong pandemic

    0 shares
    Share 0 Tweet 0
  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • Spin or Split? AT&T Has a Big Decision to Make on Discovery Stake.

    0 shares
    Share 0 Tweet 0
  • Here’s how Carl Icahn is positioning for a possible recession in America

    0 shares
    Share 0 Tweet 0
  • Some lawmakers and their families are betting thousands of dollars on crypto

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by tradingconcept.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.tradingconcept.net